Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes
Brain and Mind Institute
Although human studies have emphasized a role for IL-2 in depressive illness, limited attention has been devoted to the behavioral and neurochemical effects of this cytokine in animal studies. The present review assesses the behavioral effects of IL-2 in rodents, in counterpoint to the effects of interleukin-1β (IL-1β), necrosis factor-α (TNF-α) and endotoxin challenge. Unlike IL-1β, systemic IL-2 provokes modest effects on hypothalamic-pituitary–adrenal (HPA) functioning, and does not provoke marked signs of illness or anxiety. In some respects, however, IL-2 elicits effects reminiscent of traditional stressors, including anhedonia (diminished pleasure gained from otherwise rewarding stimuli). Additionally, when chronically administered, IL-2 may impact on cognitive processes, including spatial working memory. While IL-2 may induce depressive-like symptoms, the available data are sparse, have hardly considered the impact of chronic cytokine treatment, only assessed behavior in a narrow range of tests, and it remains to be established whether the effects of IL-2 are modifiable by antidepressant treatments. Finally, as the effects of IL-2 on CNS processes vary in a biphasic fashion, and may also engender neurotoxic effects, further analyses are necessary to discern under what conditions this cytokine provokes depressive-like behavioral outcomes.
Brain, Behavior, and Immunity
(2002). Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain, Behavior, and Immunity, 16(5), 544-556.
Available at: https://ecommons.aku.edu/bmi/365